These model-based lead-time estimates support a prostate cancer screening interval of more than 1 year.
No takes yet. Share an insight, caveat, or question.
Draisma et al. (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: